BCL6公司
染色体易位
IRF4公司
荧光原位杂交
滤泡性淋巴瘤
癌症研究
淋巴瘤
生物
内科学
肿瘤科
分子生物学
医学
基因
免疫学
转录因子
遗传学
抗体
B细胞
生发中心
染色体
作者
Mee-Jeong Kim,Hyeon‐Shik Hwang,Eun-mi Son,Hyungwoo Cho,Dok Hyun Yoon,Cheolwon Suh,Chan-Sik Park,Heounjeong Go,Jooryung Huh
标识
DOI:10.1080/10428194.2020.1815017
摘要
BCL2 translocation is the genetic hallmark of follicular lymphoma (FL). Besides BCL2 translocation, copy number (CN) gains and translocations of BCL6, MYC, and IRF4 have also been detected in FL, but there is little information regarding their prognostic significance. This retrospective study used fluorescence in situ hybridization (FISH) to analyze BCL2, BCL6, MYC, and IRF4 translocations and CN gains in 105 FL cases. Genetic translocations were detected for BCL2 (n = 64; 72.7%), BCL6 (n = 14; 15.9%), and MYC (n = 2; 2.3%); no case showed IRF4 translocation. Overall, 23 (26.1%), 30 (34.1%), 12 (13.8%), and 10 (11.0%) cases showed CN gains in BCL2, BCL6, MYC, and IRF4, respectively. BCL6 CN gain was a prognostic factor for worse overall survival, demonstrating a trend toward significance in multivariate analysis (HR =8.769, p = 0.056). BCL6 CN gain in FL might be associated with aggressive biologic behavior.
科研通智能强力驱动
Strongly Powered by AbleSci AI